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Conclusions: In a pattern population aggressively treated to reopen the 
infamt related vessel, addition of an angietensin converting enzyme inhibitor 
only influenced the process of infarct expansion and remodelling in patients 
with a severe residual stenosis in the coronary artery. 
97~'~'~-62] Thrombolyl ic  Therapy Can Be Given to Half of  
- Hospitalized PatIsnts With Acute Myocardial 
Infarction 
Christopher J. Ellis, John K. French, Barbara F. Williams, Susan Wyatt, 
June Poole, Christina Ingrain, Miles G. Williams, Hamlsh H. Hart, Harvey 
D. White. Green Lane Hospital, Auckland, New Zealand 
Despite the proven benefits of thrembelytic therapy (I"I"), only a minority of 
patients (lots) receive it (35% in the recently reported USA National Registry). 
We prospectively recorded the number of pfa eligible to receive 1"I" when 
admitted in 1993 from a I million catchment population (4 coronary care 
units, no age limits). 
Eligibility was based on ECG cdloda: > 2 mm ST elevation in leads V 1-3, > 
I mm ST elevation in any other 2 contiguous leads, or now onset of left bundle 
branch block with symptom onset within 12 hours and no contraledlcationo 
to "IT. We defined 'definite' myocardial infarction (~I) us 2 of: >_ 20 rains 
ischemlo chest pain, peak CK > 600 u/L (x 2 normal), presence of Q ~veves; 
'probable' MI as CK 300-600 u/L; 'aborted MI' as ST elevation given TT but 
with no CK dse. Over I year there were 1081 pts with 'definite' (n = 948), 
'probable' (n = 124), or 'aborted' (n = 9) Mls. 
53% (576/1081) pts were ECG edteda and time (< 12 hours) TT eligible, 
but 47 pts were 1"I" ineligible because of bleeding risk (39 detinite, 8 relative 
contralndications). Hence 49% (529/1081 ~of pts were actually TT eligible, of 
whom 470 (89%) wore., given TT. Overall hospital mortality for TT elig~le pts 
was 12.7% (11,7°/, if TT treated, 17.0% if not TT treated), 
Condusion: With standard criteria for TT, half of hospitalized pts with a 
discharge diagnos!s of MI are eligible for treatment at admission and should 
not be denied this life-saving therapy. 
~ Sfaut Assisted Direct Bal loon for Angioplasty 
Acute Myocardial Inforction, Prospective Trial 
Yashibisa Nakagawa, Hlreyoshi Yokoi, Hideyuki Nosaka, Hirsatsu Yokoi, 
Naoya Hmnasaki, Takashi Ktmura, Masaklyo NobuyoshL Kitakyushu, 
Kokura Memorial Hospital, Japan 
Thrembus formation is ~gnificant in the pathogenesls of AMI, and thrsmbus 
containing lesions have been considered to be contraindication for stenting. 
Acute reoccfuslon(AR) in CCU and silent closure($C) are major problems of 
Direct Balloon Angioplasty (DBA). From ,~=p. 1994 to June 1995, AMI patients 
(pts) under 80 years of age wore prospectively treated with now aggressive 
strategy of "Stent assisted DBA'. DBA was attempted in all AMI pts within 
12 hours of onset, except LMT infarction and cardiogenic shock. When the 
results of ,3BA was unsatisfactory and vessel size was > 3.0 ram, stent 
imptante.tion was performed subsequently. After stonflng, 3 days Hep~.rin, 
Aspirin ar¢l Coumadin were administrated as an ordinary anticoagulation 
regimen. Of the 111 pts (M/F = 92/19, age 62.4-11) ITeatsd with this protocol, 
85 pts(77%) received only DBA and 63 pts(97,6%) achieved succeesful 
repeduslon. In two pt~, DBA was failed due to massive thrembus. The rest of 
29 pts (28%) received successful etent implantation after subsptimol result 
of DBA. So overall successful reperfusion rate was 83 + 26/111 - 98,2%. 
AR In CCU occurred in 2 pts(2,3%) after DBA and subacufa thrombosis 
of stem occurred in 2 pts(7,7%). These 4 pts received repeat angiopiesty 
successfully. Two In-hospital death was documented(I.8%). Of the 109 pts 
dicharged alive, all pts received late anglogrephy(18 • 7 days). It revealed 
1 SC after DBA and there was no $C with stent, so overall late patenoy 
rate was 108/109 = 99.1%. In conclusion, stenting for suboptimal DBA had 
favorable effect to restore and sustain pataney and prevent AR and SC, 
"Sfant assisted DBA" is considered to be feasible and effective strategy for 
AMI. Further angiegraphl¢ follow up study is ongoing. 
~ Early BIo©hemlcal Markers In Bahaviour of  
Patlenls With TIMI Grade 2 Flow In the 
Infarct-Related Artery 90 Min After Thrombolysis 
for  Acute Myocardisl Inforction 
Thierry Laperche, R Gabriel Steg, PERM Study Group, France 
Dudng acute myocardial infarction (MI), Its with TIMI grade 2 flow in the 
infarct vessel have a worse prognosis than Pts with TIMI 3 flow. While 
btoct~emical morkers have been suggested for the non-lnvaslve diagnosis of 
reperfuslon early after thrembolyals, its is important o discriminate Pts with 
T1MI grade 2 flow from Pts with TIMI grade 3 flow. 
97 Pts with acute MI _< 6 h, treated with thmmbelytics, all underwent 90 
rain angibgraphy to assess flow in the infarct-vassal (TIMI grade 0-1, TIMI 
2, TIMI 3). At the onset of thrembely.qls (tO) and 90 min later (tgO), all had 
blood samples drawn to measure myoglobin (Myo), MM3/MM1 CK isoforms, 
Treponib T (l"nT) and CK-MB. The relative increase (RI = t~'~ - t0/to) over 
90 minutes were ¢P,;=ulated in each group. For all the mark~.~, studied, the 
moan to -and toO serum values were higher in TIMI 2 Its than in TIM', 3 Pts 
(p < 0.05 for Myo). RI at tg0 were consistently (but not si~'~iflcantly) ower in 
TIMI 2 Pts than in TIMI 3 PIs. In Pfa treated > 3 h after the onset of pain, 
results of RI were: 
Myo MM3/MM1 TnT CK-MB 
TIMI 0-1 2,oKa- 4 1.1+1.5 10+ °0 2.4:1:2.6 
TIMI2 4.2+4.5 0.9+0.7 9+15 2.2+2.5 
TIMI3 28.5+34 *$ 10.5+17.8 110+317 10+16 
°p < 0.05 between TIM! 0-1 and TIMI 3, l;p < 0.05 between ~MI 2 and TIMI 3. 
In conclusien, in patients treated > 3 h after onset of pain, when biochem- 
ical markers are used Io estimate thfarct-related artery patency 90 min after 
thmmbolysis, indexes based on refative increase of myoglobin at 90 min tend 
to separate patients with TIMI 2 and 3 flow. 
~ Ischemla After Thrombolysis Is Frequent, 
Somewhat Predictable, and Pre-Empted by Early 
Angio~-,~phy 
Louise Pilote, Magnus hman, Dave P. Miller, Robert M. Catiff, EdcJ. Topoi. 
GUSTO-I Investigatore, Cleveland Clinic Foundation, Cleveland, OH 
To identify predictors of recurrent isohemia after thrembelysis and to inves- 
tigate the relationship between ischemia and coronary engiography (anoio), 
we examined the GUSTO-I database. Of the 21,772 US GUSTO-I patients, 
6313 (29%) experienced ischemia before discharge. In a multiple Cox regres- 
sion, womon (RR: 1.25; 95% CI: 1.17-1.33), patients with high cholesterol 
(RR: 1.14; 95% CI: 1.07-1.22) and patients with prior angina (RR! 1.40; 95% 
Ch 1.32-1.49) had a higher likelihood of ischemia. Current smoking and time 
to thrombolysis were inversely related to ischemie (RR: 0.86; 95% CI: 0.81- 
0.92, RR: 0.97; 95% CI: 0.95-0.99, respectively). Patients who underwent 
angio had a slightly increased risk of ischemia in the 12 hours after angio 
(RFI: 1.2; 95% CI: 1.1-1.4), but ultimately, these patients had a considerably 
lower dsk 1 week after anglo than patients without anglo (RR: 0.56; 95% CI: 
0.45--0.72, Figure). 
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In conclusion, early anglo confers a net 44% reduction in ischemia at I 
week, probably h~,me high risk patients are idenf~ed and mvascuterized. 
~ A  Prospective, Randomized, Control led Study of  
Warfadn Plus Aspir in to Prevent Coronary 
Reoc~luslon After Thrombolysls 
Giovanni Melandfi, Nicolat~ Candlotfl, Fmnco Sempdnl, Vittodo Cervi, 
Latizia Baschl Regglenl, Angefo Bran:,; Bruno MagnanL Institute of 
Cardiology, University of Bofogr~ Italy 
Aspirin (A) and warfarin ON) are poor agents in the prevention of coronary 
(re)cocIuslon after thrombelysie. Since platelefs and thrombin are beth impar- 
tent mediators of coronary (,'e)thmmhosie we randomized 65 pts to receive 
either A (160 mg daily) or A (same dosage) plus W (target INR 2.5 to 3.5) 
after thrembelysis (front-loaded rt-PA). 
Coronary engiogrephy was performed within one week and after three 
months. The INR in the A + W group was 2.7 =: 0.7 at one month, 2.5:1: 
0.9 at two months and 2.5 • 0.6 at three months. 48% INR values were 
therapeutic, 46% subtherapeuflc -',nd 6% supmthempeu~c. The two groups 
did not differ in age, sex, site of infalction, risk factors. In the group ~eated 
with A + W we obselved a decrease in the overall % stenosis (74 ± 26 to 66 
29, p = 0.028) and in culprit vessel % stenosts (82 :l: 14 to 74 ± 24, p = 
0,07). In the A group changes were insignificant (66 ± 28 to 63 ± 29, p = NS 
and 77 ± 17 1O 83:1: 23, p = NS, mspacfivefy). In the A + W group the culprit 
vessel % sfanosis was improved in 43%, unchanged in 36% and worsened 
in 21%, In the A group the figures wore 8%, 36% and 56% respectively (p 
= 0.0001). When all vessels were considered, again, there was a'benofit in 
